Mexico vs Timor-Leste: Access to anti-retroviral drugs, female
Mexico
58.0%
in 2024
Timor-Leste
57.0%
in 2024
Mexico rank
105th
Timor-Leste rank
108th
Access to anti-retroviral drugs, female over time
- Mexico
- Timor-Leste
How they compare
Mexico currently reports 58.0% against 57.0% in Timor-Leste, a difference of 1.0%.
Across all 23 years both countries report, Mexico has been ahead every year.
Mexico ranks 105th and Timor-Leste ranks 108th of 141 countries.
Mexico has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mexico | Timor-Leste | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 18.0% | 1.6% | 16.4% | Mexico |
| 2010s | 44.6% | 22.1% | 22.5% | Mexico |
| 2020s | 58.6% | 49.0% | 9.6% | Mexico |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Mexico or Timor-Leste?
- Mexico, at 58.0% against 57.0% in Timor-Leste as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Mexico and Timor-Leste?
- 1.0%, with Mexico ahead.
- How many years of comparable data are there for Mexico and Timor-Leste?
- 23 years are reported by both, from 2000 to 2024.
- How do Mexico and Timor-Leste rank globally for access to anti-retroviral drugs, female?
- Mexico ranks 105th and Timor-Leste ranks 108th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.